SIGA Technologies
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 E 62nd St, New York, New York, 10065,...Phone Number
(212) 672-9100Website
www.siga.comRevenue
$53.7 MillionStock Symbol
SIGAIndustry
About SIGA Technologies
SIGA Technologies, Inc. engages in the development and commercialization of solutions for unmet medical needs and biothreats in the United States. Its lead product is TPOXX, an orally administered antiviral drug for treating orthopoxvirus infections. SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious diseases with high unmet medical needs.Explore more
SIGA Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to SIGA Technologies
Compare insights from companies similar to SIGA Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SIGA Technologies
$53.7M
11-50
Public
$12.5M
1995
Daniel LuckshireExecutive Vice President & Chief Financial Officer
SIGA Technologies Tech Stack
A closer look at the technologies used by SIGA Technologies
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SIGA Technologies
Sign Up For FreeTo access detailed company insights
SIGA Technologies, Inc. engages in the development and commercialization of solutions for unmet medical needs and biothreats in the United States. Its lead product is TPOXX, an orally administered antiviral drug for treating orthopoxvirus infections. SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious di... Read More
